Участвует в 111 реакциях

955

COc1cccc(N2CCC(C#N)CC2)c1
Reaction #391
Выход 28.5%750 AstraZeneca ELN dataset
COc1cccc(N2CCC(C#N)CC2)c1
Reaction #392
Выход 54.5%750 AstraZeneca ELN dataset
N#CC1(Cc2ccccc2)CCN(Cc2ccccc2)CC1
Reaction #1935
expected product
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_03
Cc1cc(C(=O)N(C)C(CN2CCC(C#N)CC2)C(C)C)ccc1F
Reaction #182653
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
N#CC1CCN(c2nc(Cl)nc3ccoc23)CC1
Reaction #194188
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
N#CC1CCN(CC(O)COc2cccc3ccccc23)CC1
Reaction #248727
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Cc1nc2ccccc2n1-c1nc(N2CCOCC2)c2nc(CN3CCC(C#N)CC3)n(C)c2n1
Reaction #272706
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
N#CC1CCN(c2ccc3c(C(=O)NCCC4CCCCC4)c(Cl)ccc3n2)CC1
Reaction #281427
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
Cc1ccc(C)c(NC(=O)N2CCC(C#N)CC2)c1
Reaction #296628
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
N#CC1CCN(Cc2ccc(Br)cc2)CC1
Reaction #300092
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (6/10)
N#CC1CCN(C(=O)CCl)CC1
Reaction #325847
title compound
Выход 92.9%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_02
CC(C)(C)OC(=O)N[C@@H](C(=O)N1CCC(C#N)CC1)C1CC1
Reaction #332969
[(R)-2-(4-cyanopiperidin-1-yl)-1-cyclopropyl-2-oxo-ethyl]-carbamic acid tert-butyl ester
Выход 105.8%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_02
CC(C)(C)OC(=O)N[C@@H](C(=O)N1CCC(C#N)CC1)C(C)(C)C
Reaction #332980
[(R)-1-(4-cyano-piperidine-1-carbonyl)-2,2-dimethyl-propyl]-carbamic acid tert-butyl ester
Выход 97.3%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_02
N#CC1CCN(C(=O)CCl)CC1
Reaction #377994
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (8/10)
N#CC1(Cc2ccccc2)CCN(Cc2ccccc2)CC1
Reaction #442643
expected product
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_11
N#CC1(Cc2ccccc2)CCN(Cc2ccccc2)CC1
Reaction #449891
expected product
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1999_02
CC(C)(C)OC(=O)NCCN1CCC(C#N)CC1
Reaction #475952
oil
Выход 91.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_02
N#CC1CCN(c2cccnc2OC2CN(c3ccc4ccccc4n3)C2)CC1
Reaction #542099
1-(2-((1-(quinolin-2-yl)azetidin-3-yl)oxy)pyridin-3-yl)piperidine-4-carbonitrile
Выход 40.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_07
N#CC1CCN(c2cccnc2OC2CCN(c3ccc4ccccc4n3)CC2)CC1
Reaction #542100
title product
Выход 70.0%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_07
N#CC1CCN(c2nccnc2Oc2ccc(Nc3ccccn3)cc2)CC1
Reaction #560799
1-(3-(4-(pyridin-2-ylamino)-phenoxy)pyrazin-2-yl)piperidine-4-carbonitrile
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2014_01
Страница 1Далее